Objectives: Previously, we found in cultures of primary neurons and in animals that sensitized primary neurons can be desensitized by treatment with e.g. beta-adrenergic receptor agonists. We now tested whether also in human sensitization such as UVB-radiation induced sunburn-like hyperalgesia can be reduced by intradermal injection of the beta-adrenergic receptor agonist terbutaline. Methods: In our prospective randomized study, 17 participants received an individual UVB dose to cause a defined local sunburn-like erythema at four locations, two on each forearm. Twenty-four hours later, the sensitized four areas were injected intradermally with terbutaline pH 4.3, terbutaline pH 7.0, saline pH 4.3 or saline pH 7.0, respectively. Pain thresholds were examined before and after induction of UVB-sensitization, and 15, 30 and 60 min after injection of the respective solution. Mechanical pain thresholds of the skin and of deeper tissues were determined by pinprick and pressure algometer measurements, respectively. Results: UVB-irradiation decreased mechanical pain thresholds for pinprick and pressure algometer measurements demonstrating a successful sunburn-like sensitization. Intradermal injection of terbutaline pH 7.0 into the sensitized skin reduced the sensitization for all measured timepoints as determined by pinprick measurements. Pinprick measurements of sensitization were not reduced by injection of terbutaline pH 4.3, saline solution pH 7.0 or saline solution pH 4.3. Also, sensitization of deeper tissue nociceptors were not altered by any of the injections as measured with the pressure algometer. Conclusions: Similar to our cellular observations, also in humans betaadrenergic agonists such as terbutaline can reduce the sensitization of primary neurons in the skin. Significance: We previously showed in model systems that betaadrenergic stimulation can not only sensitize but also desensitize nociceptors. Our study shows that also in humans beta-adrenergic agonists desensitize if injected into UVB-sensitized skin. This indicates an analgesic activity of adrenergic agonists in addition to their vasoconstrictory function.
Introduction
Hyperalgesia is a central problem in the clinical daily routine. The underlying mechanisms can vary significantly. One important cause of hyperalgesia is sensitization by substances such as inflammatory mediators (e.g. PGE2, histamine, serotonine), growth factors (e.g. NGF, GDNF, IGF) or hormones (e.g. oestrogen, epinephrine; Hucho and Levine, 2007; Reichling et al., 2013; Waxman and Zamponi, 2014) . According to the great variety of sensitizing extracellular mediators they act on a huge variety of receptors such as G-protein coupled receptors, hormone receptors, growth factor receptors or ion channels (Hucho and Levine, 2007; Reichling et al., 2013; Denk et al., 2017) . These ligand-activated receptors then induce intracellular signalling cascades eventually altering e.g. the opening properties of ion channels such as TRPV1, NaV1.8 and others. In experimental situations, where one such mediator is selectively applied, the onset of hyperalgesia can be abrogated by neutralizing the sensitizing mediator or by blocking the respective receptor. But in many physiological situations such as sunburninduced inflammation, there is more than one sensitizing substance present at the same time (Gustorff et al., 2004; Dawes et al., 2011) . If the presence of multiple sensitizing substances adds up resulting in more pain or if the various substances potentially even abrogate each other resulting in less pain and which pathways to address pharmaceutically in such more complex conditions has mostly not been analysed.
Previously, we analysed in detail one such sensitizing intracellular signalling cascade, the cascade towards the protein kinase C epsilon (PKCe), which is activated by agonists of the beta-adrenergic receptor and many inflammatory mediators (Khasar et al., 1999; Hucho et al., 2005 Hucho et al., , 2006 Hucho et al., , 2012 Hucho and Levine, 2007; Kuhn et al., 2008; Goswami et al., 2011) . We found a surprising dependence of the sensitizing activity on the stimulus context. In vitro and in vivo PKCe-activating substances including betaadrenergic agonists induce hyperalgesia if applied to a non-sensitized area (Khasar et al., 1999; Hucho et al., 2005 Hucho et al., , 2006 Hucho et al., , 2012 Zanelatto et al., 2018) . On the other hand in animal models, a 'sensitizing' stimulus could abrogate PKCe-dependent sensitization if applied to an already hyperalgesic tissue (Hucho et al., 2012) . The detailed cellular analysis showed that this effect was based on a 'rerouting' of the intracellular signalling cascade away from PKCe. This 'rerouting' was dependent on increased intracellular calcium levels and the activation of the calcium-dependent kinase, CaMKII, which potentially could lead to higher activity of e.g. receptor desensitizing phosphatases. If a similar context-dependent analgesic effect of PKCe-activating substances such as beta-adrenergic agonists can also be observed in humans is so far not known.
There are various models of peripheral sensitization in humans (Schmelz, 2009) . Irradiation with UVB was chosen to induce hyperalgesia since it resembles the clinical relevant pain state of sunburns. Induction of UVB-induced sensitization involves not only one but many extracellular mediators (Hucho and Levine, 2007; Dawes et al., 2011) , it can easily be applied, and UVB-induced sensitization is highly constant for many hours (Gustorff et al., 2004) . In addition, UVB inflammation produces sensory changes primarily by sensitizing peripheral pain processing with little to no changes in central pain processing (Bishop et al., 2009) .
Based on our cell biological and animal behavioural study, we therefore now tested if in humans, local injection of agonists of beta-adrenergic receptors such as terbutaline into UVB-sensitized skin would reduce already established mechanical hyperalgesia.
Materials and methods

Study design
The study was approved by the local Ethics Committee (University Clinic of Cologne, no. 14-051) according to the declaration of Helsinki. It was planned as a prospective, randomized, controlled, double-blinded investigation. After verbal and written information, all volunteers gave informed written consent to participate.
Experiments
Volunteers
Seventeen healthy male caucasian volunteers were recruited. Exclusion criteria were: serious cardiovascular, respiratory, metabolic or mental diseases, especially skin disorders; none of the volunteers was on pain medication or any other medication. During the study period, the volunteers were requested not to take any pain medication and to avoid exposure to direct sun. The studied individuals were compensated for the time spent.
UVB-induced erythema
In a pretest to identify, the UVB intensity to induce the erythema (Fig. 1, day 0) four 5-mm diameter patches of the glabrous skin at one forearm and off the future treatment injection sites were treated using a calibrated UV light source (Multitester SBC, MedLight Co., Herford, Germany). UVB light (290-320 nm) was applied with four ascending intensities (0.112-0.274 J/cm 2 , Fig. 1 ). Twenty-four hours thereafter (day 1), the spots were controlled for the degree of induced erythema. The UVB radiation intensity that induced a barely visible erythema was then tripled to induce a mild sunburn-like erythema. On each forearm two single 5-mm diameter patches (5-and 12-cm distal of the crook of the arm, respectively) were subjected to this second UVB radiation (see Fig. 2) . The painful hyperalgesia then developed over the course of the next 24 h and was tested on the subsequent day (day 2).
Measurement of pain thresholds
The measurements, pinprick and pressure algometry, were carried out in five steps: baseline of untreated skin (day 0), baseline on UVB-exposed sunburn-like areas before test substance injection (day 2), and measurements 15, 30 and 60 min after injection of the test substances into the standardized UVBinduced sunburn-like erythema (Fig. 1) .
Using a set of seven pinprick punctate probes (PinPrick Stimulator Set, MRC Systems GmbH, Heidelberg, Germany) with standardized stimulation forces (8, 16, 32, 64, 128, 256 and 512 mN) and standardized contact surface (0.2 mm diameter), the mechanical punctate pain threshold of skin innervating nociceptors was determined for each of the four spots of the volunteers. A modified method-of-limits approach was used starting with 8 mN and always doubling the pressure until the first percept of pain was reached followed by five ascending and descending stimulus intensities just above and below the threshold (Hampf et al., 1990; Chan et al., 1992; Greenspan and McGillis, 1994; Ziegler et al., 1999) . The pain threshold was calculated as the average of the five readings.
Mechanically induced pain threshold of deeper tissue nociceptors was examined with a pressure algometer (Algometer Type II, Somedic Production AB, Sollentuna, Sweden) with a probe of 1 cm 2 surface driven against the forearm (Dagtekin et al., 2007) with a progressively increasing pressure ramp of 50 kPa/s. The volunteers were instructed to indicate when the test stimulus was perceived as painful to terminate the procedure. This was executed in triplicates to determine the final pain threshold as the average of the three readings.
Injection of adrenergic receptor agonist and saline solution
The treatment solutions were injected into the areas of sunburn-like erythema on day 2. Terbutaline (Bricanyl TM , Astra Zeneca, Wedel, Germany), which is produced as a solution at pH 4.3, and saline solution 0.9% were used for the trial. To control for a potential effect of the pH, the terbutaline solution as well as the saline solution (as phosphate buffered saline, PBS) were adjusted to pH 4.3 as well as pH 7.0.
The test solutions were customized and adjusted to the required pHs at the University Clinic of Cologne pharmacy. A volume of 5 lL (2.5 lg terbutaline in saline solution or saline solution alone) was measured with a micro-pipette (Eppendorf, WesselingBerzdorf, Germany), filled into the syringe and then injected into the skin patches on each forearm. The intracutaneous injections were performed with single-use sterile insulin syringes (Becton Dickinson U-40, Micro-Fine 30 G 9 8 mm).
A single injection was performed into each of the four UVB-sensitized areas (see Fig. 2 ) at the volunteers' forearms. The four syringes were filled with the respective treatment solutions by an independent scientist in a random order leaving the examining scientist as well as the volunteer blinded for the content of the syringes.
Data analysis
For a priori sample size calculation nQuery 5 was used. A 25% change of perception was assumed for a total of five time points of measurements of mechanical pain threshold (pinprick probes and pressure algometer) (Dagtekin et al., 2007) . A total number of 17 volunteers including three possible dropouts was calculated. For a power of 80%, p < 0.05 was determined as significant.
Statistic calculations of the acquired threshold data were performed with GraphPad Prism 6 (GraphPad Sofware Inc., CA, USA). Pre-and post-UVB pinprick data were tested with Wilcoxon matched-pairs signed rank test for nonlinear populations as pinprick data are based on logarithmic increases of pressure.
The threshold measurements after treatment solution application were analysed with a two-way ANOVA repeated measurements by both factors with post hoc multiple comparisons against the 0 min timepoint. p-Values were corrected for multiple comparisons (Holm-Sidak). If not stated otherwise, data were expressed as mean AE standard error of the mean (SEM) and standard deviation (SD).
Results
Volunteers and demographics
Seventeen healthy male volunteers were examined. The volunteers were aged between 19 and 44 (mean 30.1) years. All measured volunteers were included into the analysis without any post hoc exclusion. All individuals tolerated the application of UVB radiation, injection of terbutaline and saline solution and the measurements without adverse reactions.
3.2 Injection of terbutaline pH 7.0 into UVB sensitized skin reduced the mechanical sensitivity as measured by pinprick stimulation For the induction of a mild sunburn, we followed published procedures and used three times the individually determined minimal UVB-erythema-dose on four distinct areas on the forearms of the volunteers (Fig. 1 day 1, Fig. 2 ; Gustorff et al., 2004; Bishop et al., 2009) .
Twenty-four hours after UVB-irradiation, the sunburn-like mechanical hyperalgesic thresholds were determined by pinprick measurements (Fig. 1, day  2) . The pain threshold dropped from an average of 93.65 mN AE 28.9 mN SEM with 119.2 mN SD in the control area to 26.79 mN AE 4.5 mN SEM with 18.61 mN SD after UVB-irradiation in the four test areas before treatment injection (Wilcoxon matchedpairs signed rank test for nonlinear populations, p = 0.0004, n = 17, Fig. 3A) .
Next, the four treatment solutions were injected one into each test area. The experimenter as well as the volunteers were blindfolded, which of the four solutions (terbutaline pH 7.0, terbutaline pH 4.3, PBS pH 7.0, PBS pH 4.3) was injected into which of the four UVB-induced sunburn areas. 15, 30 and 60 min after injection the mechanical thresholds were measured by pinprick stimulation.
In line with our previously published cellular and animal behaviour data, intradermal injection of terbutaline pH 7.0 into the UVB-treated and thus hyperalgesic skin resulted in a reduction of the sensitization as observed by an increase in the pain threshold for pinprick stimulation in comparison with the NaCl pH 7.0 control group (Fig. 4 , two-way repeated measurement ANOVA, time F(3, 48) = 1.527, p = 0.2195; treatment F(3, 48) = 5.292, p = 0.0031; interaction of time 9 treatment F(9, 144) = 2.054, p = 0.00375, n = 17). Average values increased in response to the treatment from 27.8 mN AE 6.0 mN SEM with AE24.7 mN SD to 66.8 mN AE 18.3 mN SEM with AE75.5 mN SD after 15 min (Holm-Sidak corrected post hoc multiple comparison test, p < 0.0001). This sensitization remained reduced also at 30 min (66.2 mN AE 19.9 mN SEM with 82.1 mN SD; p = 0.0008) and was still significantly reduced after 60 min (46.4 mN AE 12.5 mN SEM with AE51.4 mN SD; p = 0.0236; Table 1 and Fig. 4) . In contrast, injection of saline control solution at pH 7.0 did not reduce the established hyperalgesia (27.3 mN AE 8.6 mN SEM with 35.3 mN SD at baseline, 23.2 mN AE 6.9 mN SEM with AE28.3 mN SD after 15 min, 30.4 mN AE 8.4 mN SEM with 34.8 mN SD after 30 min, 20.7 mN AE 4.4 SEM with 18.2 mN SD after 60 min (n = 17, Fig. 4 ).
Injection of terbutaline pH 4.3 and saline pH 4.3 into UVB-sensitized skin did not change the mechanical sensitivity as measured by pinprick stimulation
Terbutaline is commonly supplied as a solution at pH 4.3. Thus, we also tested the influence of terbutaline at pH 4.3 as well as of saline at pH 4.3 in comparison to the saline pH 7.0 control for an influence on pain sensitization thresholds as measured by pinprick stimulation. Neither of the injected solutions did reduce the mechanical sensitivity (Table 1 and Fig. 4) . The UVB-induced hyperalgesic pain thresholds remained stable after 15, 30 and 60 min.
3.4 Injection of terbutaline pH 7.0, terbutaline pH 4.3, saline pH 7.0 and saline pH 4.3 into UVB sensitized skin did not change the mechanical sensitivity as measured by pressure algometer UVB-irradiation results in mechanical hyperalgesia also if measured with a pressure algometer (Gustorff et al., 2013) , which detects preferentially nociceptor thresholds of deep tissue nociceptors with little to no influence of skin nociceptors (Kosek et al., 1996) . As reported by others, also in our study UVB-induced erythema resulted in a drop of the pain threshold in the control area from 461.2 kPa AE 32.3 kPa SEM with AE133.3 kPa SD to 256.6 kPa AE 19.89 kPa SEM with AE82.0 kPa SD in the averaged four UVBexposed test areas before treatment injection (t-test, two tailed, p < 0.0001, n = 17, Fig. 3B ).
We tested if the UVB-induced sensitization also of presumably deeper tissue nociceptors was affected by intradermal injection of terbutaline and/or saline. In contrast to the sensitization of skin innervating nociceptors as measured by pinprick stimulation, the injections of terbutaline and saline at neither of the two pHs, pH 7.0 and 4.3, did not alter the UVB-induced sensitization (Table 2 and Fig. 5 ). The pain thresholds remained stable after 15, 30 and 60 min.
Discussion
Mostly adrenergic agonists are described to induce pain sensitization (Khasar et al., 1999 (Khasar et al., , 2003 Aley and Levine, 2003; Chen and Levine, 2005; Hucho et al., 2005) . Accordingly, also blockers of beta adrenergic receptors have been shown to abrogate the onset of hyperalgesia (Zanelatto et al., 2018) . But also pain-relieving activities of beta-adrenergic agonists have been reported. Amann and Schuligoi (2004) describe terbutaline to reduce NGF production in the rat capsaicin model of pain in a prostaglandin-independent manner. Also in mouse models of neuropathic pain such as nerve cuffing or diabetes, agonists of beta-adrenergic receptors have been shown to induce analgesia (Choucair-Jaafar et al., 2009 . And last but not least, activation of beta2-adrenergic receptors in the spinal cord resulted in amelioration of neuropathic pain induced by partial sciatic nerve ligation (Zhang et al., 2016) .
Our study expands the current knowledge about analgesic effects of beta adrenergic receptor agonists. We show that UVB-induced mechanical sensitization can be reduced by injection of the beta adrenergic receptor agonist terbutaline at pH 7.0 if injected into the sensitized peripheral area. In contrast, injection of terbutaline at pH 4.3 and of saline solution at pH 4.3 or 7.0 did not reduce mechanical hypersensitivity. Maximal reduction was achieved after 15 and 30 min and decreased slightly after 60 min (Fig. 4) . The reduction of the UVB-induced sensitization could be achieved for the skin innervating nociceptors as measured by the pinprick method but not for deeper tissue nociceptors as measured by pressure algometry. These observations support our previous findings in primary sensory neurons and animal behaviour experiments (Hucho and Levine, 2007; Hucho et al., 2012 ). There we described, that substances, which are known to sensitize nociceptive neurons can also desensitize these neurons as well. The outcome of the treatment was dependent on the state of the neuron. If added to a na€ ıve neuron, the outcome was sensitization. If the neuron was already sensitized, the substance had a desensitizing effect instead (Hucho et al., 2012) .
How can one and the same receptor system have such opposing effect? In our previous study, we analysed the underlying cellular mechanism in detail (Hucho et al., 2006 (Hucho et al., , 2012 . We used extracellular mediators, which are known to involve one special intracellular signalling cascade involving the protein kinase C epsilon. A number of different extracellular substances known to result in protein kinase C epsilon-dependent mechanical hyperalgesia were chosen, including one agonist of the beta-adrenergic receptor. We found, that the extracellular mediator induced intracellular signalling irrespective if the outcome was sensitization or desensitization. Thus, apparently, the differential physiological outcome was not the result of a common ligand-induced receptor desensitization. Instead, the intracellular signalling was rerouted. This could potentially result in the activation of desensitizing phosphatases. In our previous study, we described this mechanism cell biologically in cultured rat primary sensory neurons, electrophysiologically in rat nociceptive fibres in the living animal, as well as behaviourally in living rats (Hucho et al., 2012) . We would like to argue that our new results about analgesic effects of terbutaline in UVB-sensitized skin in humans is likely to follow the mechanism of signalling rerouting as described mechanistically by us previously in rat. This notion is based on comparisons of the time-course and location of action. In our previous cellular study, the rerouting effect was immediate, was observed in IB4-positive neurons which are known to innervate the skin, and was initiated in the living animal by intradermal injections (Hucho et al., 2012) . In humans, we now find a fast activity resulting in analgesia at its earliest timepoint of testing after 15 min by a local intradermal injection. We would like to suggest that this mechanism is different from the ones reported by Amann et al. and Choucair-Jaafar et al. They report analgesic action of beta-adrenergic receptor agonists NGF to be produced by nonneuronal cells. Further, there the beta adrenergic agonist has another time dimension acting rather after hours than within minutes (Amann and Schuligoi, 2004) . In the studies of Choucair-Jaafar et al. (2009, 2014) , the effect was mediated by receptors along the nociceptive system but not localized to the peripheral termini in the skin. In addition, short-term application remained without effect and long-term treatment was required instead. And last but not least, Zhang et al. (2016) applied the beta adrenergic agonists not to the skin but to the spinal cord and suggest the analgesic effect to be mediated by signalling events in non-neuronal cells such as glia.
An interesting side aspect of our study expanding our cellular experiments is the test for an influence of the pH. As terbutaline is prepared for clinical use at a pH of 4.3, we included solutions not only at pH 7.0 but also at 4.3. We now find physiological saline injection at pH 4.3 not to alter UVB-induced mechanical sensitization. In contrast to pH 7.0, also terbutaline does not present an analgesic effect if given at pH 4.3. While an elucidation of the underlying mechanism requires further experiments, the result is in line with general GPCR biology. Mostly, signalling of GPCRs after ligand binding is abrogated by internalization of the receptor into endosomes and the acidification of the endosomal lumen which in turn reduces the binding affinity of the ligand to the receptor and results in its dissociation. Similarly here, the low pH most likely does not allow effective binding of terbutaline to the beta adrenergic receptor and thus does not initiate the respective intracellular signalling in the first place. But this interpretation asks for a note of caution. To accomplish clinical relevance, we used commercially supplied clinically used preparations of terbutaline, which are dissolved in physiological salt solution with extremely limited pH buffer capacity. Thus, while it is possible to measure and adjust the pH in the laboratory, the pH is prone to quick and drastic changes due to e.g. changes in the CO 2 concentration of the tissue in contrast to the laboratory atmosphere and/or the local pH condition at the injection site. Future studies using a terbutaline solution with higher buffer capacity appear necessary and of interest. Such experiments would be especially interesting in the context of results of others such as Jones et al. (2004) . There, the authors demonstrated that continuous iontophoresis of protons caused moderate pain reaching a peak after about 1 min. However, additional iontophoresis of acid resulted in progressive desensitization lasting many hours. Potentially, also this could be an indication of a rerouting of a sensitizing stimulus signalling into a desensitizing activity.
In conclusion, in the presented study we find, that in agreement with our cellular and behavioural studies also in humans one agonist of the beta-adrenergic receptor system can result in a significant reduction of established mechanical hyperalgesia in sensitized skin. While predicted by our cellular and animal study, this result is of considerable interest. First of all it suggests that the categorization of stimuli as sensitizing or desensitizing is an oversimplification as the outcome is highly context dependent. Second, it suggests that the analysed mechanism appears to be a general mechanism in place in various species. And third, it indicates that the mechanism is not only in place for nociceptor sensitization induced by experimental injections of single substances but also in a more physiological model such as sunburn-induced hyperalgesia, where many sensitizing substances are produced.
While our results spur a number of questions, which go far beyond what has been approved by the ethical board, our study shows in conclusion, that chemical stimulation reduces already sensitized primary neurons in the model of UVB-induced sunburn in humans.
